Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostate | 14 | 2019 | 448 | 3.660 |
Why?
|
| Epithelial Cells | 13 | 2019 | 932 | 2.040 |
Why?
|
| Stem Cells | 9 | 2019 | 747 | 1.650 |
Why?
|
| Prostatic Neoplasms | 8 | 2017 | 1602 | 1.480 |
Why?
|
| PTEN Phosphohydrolase | 9 | 2016 | 258 | 1.440 |
Why?
|
| Receptors, Notch | 4 | 2015 | 214 | 1.160 |
Why?
|
| Prostatic Hyperplasia | 2 | 2016 | 118 | 0.970 |
Why?
|
| Cell Lineage | 6 | 2016 | 366 | 0.880 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2013 | 150 | 0.760 |
Why?
|
| Polymyxin B | 1 | 2022 | 47 | 0.750 |
Why?
|
| Cell Differentiation | 10 | 2016 | 2026 | 0.740 |
Why?
|
| Cell Proliferation | 11 | 2019 | 2559 | 0.740 |
Why?
|
| Receptors, Androgen | 5 | 2017 | 432 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 4823 | 0.570 |
Why?
|
| Ribonuclease III | 3 | 2013 | 103 | 0.550 |
Why?
|
| Homeostasis | 3 | 2016 | 748 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2016 | 637 | 0.540 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 53 | 0.500 |
Why?
|
| AC133 Antigen | 1 | 2016 | 37 | 0.500 |
Why?
|
| Androgens | 2 | 2015 | 297 | 0.500 |
Why?
|
| Mice, Transgenic | 8 | 2016 | 2521 | 0.490 |
Why?
|
| Mice | 21 | 2019 | 18928 | 0.470 |
Why?
|
| Ataxin-1 | 1 | 2015 | 162 | 0.460 |
Why?
|
| Stromal Cells | 4 | 2019 | 314 | 0.450 |
Why?
|
| Animals | 26 | 2019 | 36184 | 0.440 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 241 | 0.440 |
Why?
|
| Carcinogenesis | 2 | 2015 | 361 | 0.440 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2013 | 9 | 0.430 |
Why?
|
| Prostatitis | 1 | 2013 | 16 | 0.420 |
Why?
|
| Keratin-8 | 2 | 2015 | 11 | 0.410 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 361 | 0.400 |
Why?
|
| Signal Transduction | 7 | 2016 | 4915 | 0.390 |
Why?
|
| Endoribonucleases | 2 | 2010 | 86 | 0.390 |
Why?
|
| Integrases | 2 | 2015 | 163 | 0.370 |
Why?
|
| Macrophages | 1 | 2016 | 697 | 0.370 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2012 | 94 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 2 | 2019 | 481 | 0.350 |
Why?
|
| Apoptosis | 4 | 2015 | 1928 | 0.350 |
Why?
|
| Amides | 1 | 2011 | 86 | 0.340 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 51 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2575 | 0.340 |
Why?
|
| Inflammation | 2 | 2016 | 1556 | 0.320 |
Why?
|
| Cell Movement | 1 | 2013 | 906 | 0.310 |
Why?
|
| Pyridines | 1 | 2011 | 250 | 0.310 |
Why?
|
| Male | 21 | 2019 | 65478 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 2125 | 0.290 |
Why?
|
| MicroRNAs | 3 | 2011 | 945 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2017 | 3978 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 612 | 0.250 |
Why?
|
| Keratin-14 | 2 | 2016 | 9 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 3 | 2016 | 336 | 0.220 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2650 | 0.220 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 3794 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 1325 | 0.210 |
Why?
|
| Regeneration | 2 | 2016 | 228 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 511 | 0.160 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 479 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 835 | 0.160 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 24 | 0.150 |
Why?
|
| Epithelium | 2 | 2016 | 354 | 0.140 |
Why?
|
| Disease Progression | 2 | 2015 | 2242 | 0.140 |
Why?
|
| beta Catenin | 2 | 2019 | 231 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2016 | 249 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2016 | 441 | 0.130 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 11 | 0.130 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 7 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 452 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2019 | 614 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2013 | 1136 | 0.130 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 53 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 91 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 64 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 186 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 121 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 167 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 51 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 3131 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 218 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 69 | 0.120 |
Why?
|
| Cell Shape | 1 | 2015 | 70 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 883 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 402 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 529 | 0.110 |
Why?
|
| Anoikis | 1 | 2014 | 9 | 0.110 |
Why?
|
| Humans | 14 | 2019 | 133181 | 0.110 |
Why?
|
| Tamoxifen | 2 | 2015 | 375 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 781 | 0.110 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 9 | 0.110 |
Why?
|
| Hyperplasia | 1 | 2013 | 195 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 910 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 252 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2012 | 6 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2013 | 2718 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 1067 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 318 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 348 | 0.100 |
Why?
|
| Organoids | 1 | 2015 | 301 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 606 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 176 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2017 | 871 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 477 | 0.090 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 110 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2013 | 200 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1097 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 69 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2012 | 185 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 545 | 0.090 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 63 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2012 | 391 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 79 | 0.090 |
Why?
|
| Transgenes | 1 | 2012 | 344 | 0.090 |
Why?
|
| Clone Cells | 1 | 2011 | 180 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 328 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2012 | 640 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1340 | 0.080 |
Why?
|
| Biological Assay | 1 | 2011 | 111 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2011 | 225 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 177 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1013 | 0.080 |
Why?
|
| Atrophy | 1 | 2010 | 231 | 0.080 |
Why?
|
| Lentivirus | 1 | 2009 | 86 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 584 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 231 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 400 | 0.080 |
Why?
|
| Organ Size | 1 | 2010 | 463 | 0.080 |
Why?
|
| Multigene Family | 1 | 2010 | 321 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1914 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2011 | 713 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 1280 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1730 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 814 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 1692 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2876 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2009 | 965 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 4754 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1757 | 0.050 |
Why?
|
| Female | 6 | 2016 | 71395 | 0.050 |
Why?
|
| Biomarkers | 1 | 2011 | 3411 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 37 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 58 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 206 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2017 | 28 | 0.030 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2017 | 43 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2017 | 66 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 50 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 167 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 96 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 138 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2015 | 50 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 165 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 183 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 126 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 340 | 0.030 |
Why?
|
| Cell Division | 1 | 2015 | 765 | 0.030 |
Why?
|
| Metribolone | 1 | 2013 | 31 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 46 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 137 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 126 | 0.020 |
Why?
|
| Glycolysis | 1 | 2013 | 173 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 398 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1420 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 546 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 899 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 699 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 165 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2011 | 58 | 0.020 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 45 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 55 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 432 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 399 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 456 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 619 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 755 | 0.020 |
Why?
|
| Ovary | 1 | 2011 | 386 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5191 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 835 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 467 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 788 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2855 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2751 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 6340 | 0.010 |
Why?
|